更加迫在眉睫的问题与控制原始捐赠和源于诱导多能干细胞的组织培养有关。
More immediate concerns have to do with control of the original donation and tissue grown from iPS cells.
一些道德家建议说，组织捐赠者应保留这样的权利，即能够分享诱导多能干细胞系作为疾病模型，药物测试平台以及治疗方案所带来的潜在的巨大商业利益。
Some ethicists suggest that tissue donors deserve a share of the tremendous commercial potential of iPS cell lines as disease models, drug-testing platforms or treatments.
作为多能的证明，研究人员把鬼狒和犀牛的iPS细胞诱导去制造三种不同的简单组织，这些简单组织可以生长出身体上的所有其他组织。
As proof of pluripotency, the researchers coaxed the drill and rhino iPS cells into making the three different kinds of simple tissues that produce all the other tissues in the body.
应用推荐